# Deferoxamine Methansulphonate

## DesFERAL inj 500mg

| 藥物代碼 | IDES |
| :--- | :--- |
| 適應症 | Transfusional hemosiderosis especially in thalassemia major; idiopathic hemochromatosis; porphyria cutanea tarda. Acute Fe poisoning. Chronic Al overload with Al-related disease &/or encephalopathy. Test for Fe & Al overload. |
| 副作用 | Rarely, allergic skin reactions, anaphylactic reactions; local irritation at inj site; audiovisual disturbances, lens opacities; GI disturbances; leg cramps; renal or hepatic impairment; reddish brown urine discoloration; thrombocytopenia; CV & neurological disturbances. |
| 禁忌 | Known hypersensitivity to the active substance, except where desensitisation proves possible. |
| 藥物保存方式 | N/A |
| 用法用量 | If the patient is normotensive, Desferal is usually given in a single IM dose: 2 g for an adult and 1 g for a child. If the patient is hypotensive, the IV route is recommended. The maximum rate for administration IV is 15 mg/kg/hr and is reduced after 4-6 hrs so that the total IV dose in general does not exceed 80 mg/kg/24 hrs. In an adult patient with severe iron poisoning even infusion of 37.1 g Desferal over 52 hrs has been tolerated without apparent unwanted effects. Therapy should be continued until the serum iron levels are less than the total iron-binding capacity. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IM, IVD, SC |
| 乾粉稀釋液 | 需先以5ml注射用水稀釋成10% Desferal，方可使用。 |
| 輸注點滴液 | 【D5W】 可選  【L/R】 可選  【N/S】 可選 |
| IVP 用法建議 | N/A |
| IVD 用法建議 | 注射速率 &lt; 15mg/kg/hr |
| 注意事項 | 1.限用5mL注射用水溶解乾粉, 不可用 0.9% N/S作為乾粉藥劑之溶劑 2.溶解後可用0.9% N/S做進一步的稀釋 |

